Share on LinkedInShare on LinkedIn

ARTICLE · 16 OCTOBER 2024

G 1/23 - Potential Changes Ahead For What Constitutes "State Of The Art"?

The EPO Enlarged Board of Appeal's preliminary opinion on G 1/23 suggests overturning G 1/92, concluding that a publicly available product constitutes prior art, even if its composition is irreproducible. This could impact patent strategies across various industries, pending a final decision.

United KingdomIntellectual Property

The EPO Enlarged Board of Appeal has now issued its preliminary (and non-binding) opinion on G 1/23. This referral (from the Technical Board of Appeal in T 438/19) seeks to clarify whether a commercially available product, with an undisclosed composition or internal structure, must be analysable and reproducible by the skilled person in order to constitute prior art under Article 54(2) EPC.

G 1/23 vs. G 1/92

The preliminary opinion on G 1/23 appears to overturn G 1/92, which had previously concluded that for a product to become prior art, the skilled person must be able to determine the composition of the product and then reproduce it without undue burden. Amongst its reasoning in the preliminary opinion, the Enlarged Board on G 1/23 states that G 1/92 "would directly lead to the result that irreproducible products would effectively cease to exist for the purposes of the EPC. The Enlarged Board is of the opinion that such an extreme result could not have been

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from